Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2021 | Biomarker updates at EHA 2021

Darko Antic • 24 May 2021
EHA 2021
General

Darko Antic, MD, PhD, University of Belgrade, School of Medicine, Belgrade, Serbia, shares what he’s looking forward to at the virtual European Hematology Association (EHA) Congress 2021, highlighting updates on the use of biomarkers in patients with hematological malignancies and their role in precision medicine and in the field of cellular therapies.

Disclosures

Darko Antic, MD, PhD, has received honoraria from Roche, Sandoz, Takeda and Johnson & Johnson.

More from Darko Antic

4:19
Predictive value of the ThroLy score in Hodgkin lymphoma
Darko Antic • 24 May 2021

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals